BBO-11818

· The Ras, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BBO-11818, covering 2026-03-23 to 2026-03-23. Get the full timeline:

Most recent: Clinical Trial Update: BBO-11818 in Adult Subjects With KRAS Mutant Cancer [Phase 1]